Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1994 1
1995 2
1996 7
1997 3
1999 1
2000 3
2001 4
2003 2
2004 3
2005 11
2006 14
2007 12
2008 14
2009 7
2010 3
2011 5
2012 6
2013 8
2014 6
2015 6
2016 9
2017 12
2018 6
2019 8
2020 6
2021 6
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

145 results
Results by year
Filters applied: . Clear all
Page 1
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial.
Kwon ED, Drake CG, Scher HI, Fizazi K, Bossi A, van den Eertwegh AJ, Krainer M, Houede N, Santos R, Mahammedi H, Ng S, Maio M, Franke FA, Sundar S, Agarwal N, Bergman AM, Ciuleanu TE, Korbenfeld E, Sengeløv L, Hansen S, Logothetis C, Beer TM, McHenry MB, Gagnier P, Liu D, Gerritsen WR; CA184-043 Investigators. Kwon ED, et al. Lancet Oncol. 2014 Jun;15(7):700-12. doi: 10.1016/S1470-2045(14)70189-5. Epub 2014 May 13. Lancet Oncol. 2014. PMID: 24831977 Free PMC article. Clinical Trial.
Immunotherapy in prostate cancer.
Sobol I, Thompson RH, Dong H, Krco C, Kwon ED. Sobol I, et al. Among authors: kwon ed. Curr Urol Rep. 2015 Jun;16(6):34. doi: 10.1007/s11934-015-0509-7. Curr Urol Rep. 2015. PMID: 25894495 Review.
Immunotherapy for prostate cancer.
Karnes RJ, Whelan CM, Kwon ED. Karnes RJ, et al. Among authors: kwon ed. Curr Pharm Des. 2006;12(7):807-17. doi: 10.2174/138161206776056001. Curr Pharm Des. 2006. PMID: 16515497 Review.
Costimulation, coinhibition and cancer.
Inman BA, Frigola X, Dong H, Kwon ED. Inman BA, et al. Among authors: kwon ed. Curr Cancer Drug Targets. 2007 Feb;7(1):15-30. doi: 10.2174/156800907780006878. Curr Cancer Drug Targets. 2007. PMID: 17305475 Review.
Prostate cancer post-treatment follow-up and recurrence evaluation.
May EJ, Viers LD, Viers BR, Kawashima A, Kwon ED, Karnes RJ, Froemming AT. May EJ, et al. Among authors: kwon ed. Abdom Radiol (NY). 2016 May;41(5):862-76. doi: 10.1007/s00261-015-0562-1. Abdom Radiol (NY). 2016. PMID: 27193788 Review.
Costimulatory wars: the tumor menace.
Hurwitz AA, Kwon ED, van Elsas A. Hurwitz AA, et al. Among authors: kwon ed. Curr Opin Immunol. 2000 Oct;12(5):589-96. doi: 10.1016/s0952-7915(00)00147-3. Curr Opin Immunol. 2000. PMID: 11007364 Review.
Prostate cancer: advances in immunotherapy.
Hurwitz AA, Yanover P, Markowitz M, Allison JP, Kwon ED. Hurwitz AA, et al. Among authors: kwon ed. BioDrugs. 2003;17(2):131-8. doi: 10.2165/00063030-200317020-00005. BioDrugs. 2003. PMID: 12641491 Review.
Regulation of gene expression by hypertonicity.
Burg MB, Kwon ED, Kültz D. Burg MB, et al. Among authors: kwon ed. Annu Rev Physiol. 1997;59:437-55. doi: 10.1146/annurev.physiol.59.1.437. Annu Rev Physiol. 1997. PMID: 9074772 Review.
145 results